These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5536884)

  • 1. Tolbutamide study raises blood pressures.
    Nature; 1970 Dec; 228(5278):1251-2. PubMed ID: 5536884
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolbutamide: hazards of leaks.
    Nature; 1970 Jul; 227(5255):224-5. PubMed ID: 4913637
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: The UGDP scandal and cover-up.
    Moss JM
    JAMA; 1975 May; 232(8):806-8. PubMed ID: 1173182
    [No Abstract]   [Full Text] [Related]  

  • 4. The tolbutamide Controversy: a personal perspective.
    Schwartz TB
    Ann Intern Med; 1971 Aug; 75(2):303-6. PubMed ID: 5558655
    [No Abstract]   [Full Text] [Related]  

  • 5. The University Group Diabetes Program. A statistician looks at the mortality results.
    Schor S
    JAMA; 1971 Sep; 217(12):1671-5. PubMed ID: 4937385
    [No Abstract]   [Full Text] [Related]  

  • 6. Status of problem of usage of tolbutamide. Preliminary statements.
    Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolbutamide: more questions than answers.
    Barclay WR
    JAMA; 1971 Jan; 215(1):108-9. PubMed ID: 5107341
    [No Abstract]   [Full Text] [Related]  

  • 8. The University Group Diabetes Program. A further statistical analysis of the mortality findings.
    Cornfield J
    JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386
    [No Abstract]   [Full Text] [Related]  

  • 9. The FDA and hypoglycemic drugs.
    Davidson JK
    JAMA; 1975 May; 232(8):853-5. PubMed ID: 1091764
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Let's stop the Donnybrook. A perspective on the UGDP-Biometric Society Study.
    Moser RH
    JAMA; 1975 Mar; 231(12):1274-6. PubMed ID: 1172958
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
    Gray RH
    Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical guest editorial: The oral diabetic drug controversy.
    Am Fam Physician; 1975 Dec; 12(6):73-4. PubMed ID: 1202930
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of adult-onset diabetes. The impact of the University Group Diabetes Program.
    Goetz FC
    Postgrad Med; 1972 Jul; 52(1):63-8. PubMed ID: 5067890
    [No Abstract]   [Full Text] [Related]  

  • 14. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP).
    Seltzer HS
    Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722
    [No Abstract]   [Full Text] [Related]  

  • 15. The Tolbutamide evidence.
    Lancet; 1971 Jan; 1(7691):171-2. PubMed ID: 4102190
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolbutamide: another view.
    Nahum LH
    Conn Med; 1971 Apr; 35(4):272-3. PubMed ID: 5108037
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled clinical trials and the tolbutamide controversy.
    Lavietes PH
    Conn Med; 1971 Apr; 35(4):271-2. PubMed ID: 4927818
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug fears dismissed.
    Nature; 1970 Nov; 228(5272):599. PubMed ID: 4920015
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorials: Statistical problems in clinical trials: the UGDP study revisited.
    Schor SS
    Am J Med; 1973 Dec; 55(6):727-32. PubMed ID: 4584989
    [No Abstract]   [Full Text] [Related]  

  • 20. The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
    Kilo C; Miller JP; Williamson JR
    Diabetologia; 1980 Mar; 18(3):179-85. PubMed ID: 6989693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.